Reltecimod, a CD28 antigen inhibitor, is used potentially for the treatment of necrotizing soft tissue infection.

1447799-33-8

C46H72N10O15S

1037.19

AB-103;AB103;P-2TA;NSC-37096;P2TA;Reltecimod

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years